ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: henryw	4/4/2011 12:03:30 PM
	of 1084

Aastrom (ASTM) Manufacturing Transfer and CLI Product Naming Manufacturing steps completed in preparation for PIII CLI Program ASTM transferred cell cassette manufacturing to ATEK Medical under the 10/10 partnership. These single-use cell cassettes are the central component used in its proprietary culturing process at its cell manufacturing facility. Ixmyelocel-T has been formally accepted by the US FDA and the Adopted Names Council as the non-proprietary name for ASTM’s investigational cell therapy product. The Bottom Line: Packaged noise, not milestones but, Needham & Co’s “BUY” and $6.00 price target stimulated share appreciation. However, recognize this is the press build-up pre one SPA approval which will substantiate a … very … dilutionary offering by Needham and Stifel. Needham also came out with a “BUY” on Pluristem (PSTI), ASTM’s comparable at $5.00. Just, keeping the banking fee “pot” warm!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next